Kelly Thomas Patrickinsider trades
In SEC Form 4 filings, Kelly Thomas Patrick is listed as Chief Financial Officer of Xenon Pharmaceuticals Inc. (XENE). In the last 90 days, Kelly Thomas Patrick bought $559.7K of Xenon Pharmaceuticals Inc. (XENE) on the open market and sold none. The purchase was $559.7K of Xenon Pharmaceuticals Inc. (XENE) on Sep 30. Took part in a cluster buy; the latest at Xenon Pharmaceuticals Inc. (XENE), where 2 insiders bought within 1 day, ending Sep 30.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | Chief Financial Officer | 3 | Oct 16 |
Cluster buys
- XENE: 2 insiders bought $1.68M between Sep 30.
Form 4 historysince 2026-10-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | Oct 15 | Oct 16 | M | 7,500 | not reported | not reported | 22,500 | No | Form 4 |
| XENEXenon Pharmaceuticals Inc. | Oct 15 | Oct 16 | M · derivative | 7,500 | $0.00 | $0 | 22,500 | No | Form 4 |
| XENEXenon Pharmaceuticals Inc. | Sep 30 | Oct 1 | P | 15,000 | $37.32 | Purchase +$559,740 | 15,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.